Global RNA Based Therapeutics Market Size, Status and Forecast 2027

Table of Contents

Global RNA Based Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of RNA Based Therapeutics
1.1 RNA Based Therapeutics Market Overview
1.1.1 RNA Based Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global RNA Based Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 RNA Based Therapeutics Market by Type
1.3.1 Microarrays
1.3.2 Labeling
1.3.3 Purification
1.3.4 Linear amplification
1.3.5 qRT-PCR
1.3.6 Inhibition
1.3.7 RNA Interference (RNAi) technologies
1.3.8 RNA antisense technologies
1.4 RNA Based Therapeutics Market by End Users/Application
1.4.1 Cardiovascular
1.4.2 Kidney Diseases
1.4.3 Oncology
1.4.4 Infectious diseases
1.4.5 Metabolic disorders
1.4.6 Others

2 Global RNA Based Therapeutics Competition Analysis by Players
2.1 RNA Based Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Quark Pharmaceuticals
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Alnylam Pharmaceuticals
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Dicerna Pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Tekmira Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Benitec Biopharma Limited
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Genzyme Corporation
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 ISIS pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Silence Therapeutics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Cenix BioScience
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 RNA Based Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments

4 Global RNA Based Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global RNA Based Therapeutics Market Size by Type (2012-2017)
4.2 Global RNA Based Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of RNA Based Therapeutics in Future
4.4 Top Consumer/End Users of RNA Based Therapeutics

5 United States RNA Based Therapeutics Development Status and Outlook
5.1 United States RNA Based Therapeutics Market Size (2012-2017)
5.2 United States RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU RNA Based Therapeutics Development Status and Outlook
6.1 EU RNA Based Therapeutics Market Size (2012-2017)
6.2 EU RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan RNA Based Therapeutics Development Status and Outlook
7.1 Japan RNA Based Therapeutics Market Size (2012-2017)
7.2 Japan RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China RNA Based Therapeutics Development Status and Outlook
8.1 China RNA Based Therapeutics Market Size (2012-2017)
8.2 China RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India RNA Based Therapeutics Development Status and Outlook
9.1 India RNA Based Therapeutics Market Size (2012-2017)
9.2 India RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia RNA Based Therapeutics Development Status and Outlook
10.1 Southeast Asia RNA Based Therapeutics Market Size (2012-2017)
10.2 Southeast Asia RNA Based Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global RNA Based Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia RNA Based Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global RNA Based Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global RNA Based Therapeutics Market Size by Application (2017-2022)

12 RNA Based Therapeutics Market Dynamics
12.1 RNA Based Therapeutics Market Opportunities
12.2 RNA Based Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 RNA Based Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 RNA Based Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source



List of Tables and Figures

Figure RNA Based Therapeutics Product Scope
Figure Global RNA Based Therapeutics Market Size (Million USD) (2012-2017)
Table Global RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNA Based Therapeutics Market Share by Regions in 2016
Figure United States RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global RNA Based Therapeutics Market Share by Type in 2016
Figure Microarrays Market Size (Million USD) and Growth Rate (2012-2017)
Figure Labeling Market Size (Million USD) and Growth Rate (2012-2017)
Figure Purification Market Size (Million USD) and Growth Rate (2012-2017)
Figure Linear amplification Market Size (Million USD) and Growth Rate (2012-2017)
Figure qRT-PCR Market Size (Million USD) and Growth Rate (2012-2017)
Figure Inhibition Market Size (Million USD) and Growth Rate (2012-2017)
Figure RNA Interference (RNAi) technologies Market Size (Million USD) and Growth Rate (2012-2017)
Figure RNA antisense technologies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global RNA Based Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Cardiovascular
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
Table Key Downstream Customer in Kidney Diseases
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Kidney Diseases (2012-2017)
Table Key Downstream Customer in Oncology
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
Table Key Downstream Customer in Infectious diseases
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Infectious diseases (2012-2017)
Table Key Downstream Customer in Metabolic disorders
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Metabolic disorders (2012-2017)
Table Key Downstream Customer in Others
Figure RNA Based Therapeutics Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table RNA Based Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure RNA Based Therapeutics Market Size Share by Players in 2016
Figure RNA Based Therapeutics Market Size Share by Players in 2017
Table Quark Pharmaceuticals Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Quark Pharmaceuticals (2012-2017)
Figure Quark Pharmaceuticals RNA Based Therapeutics Business Revenue Market Share in 2016
Table Alnylam Pharmaceuticals Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Alnylam Pharmaceuticals (2012-2017)
Figure Alnylam Pharmaceuticals RNA Based Therapeutics Business Revenue Market Share in 2016
Table Dicerna Pharmaceuticals Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Dicerna Pharmaceuticals (2012-2017)
Figure Dicerna Pharmaceuticals RNA Based Therapeutics Business Revenue Market Share in 2016
Table Tekmira Pharmaceuticals Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Tekmira Pharmaceuticals (2012-2017)
Figure Tekmira Pharmaceuticals RNA Based Therapeutics Business Revenue Market Share in 2016
Table Benitec Biopharma Limited Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Benitec Biopharma Limited (2012-2017)
Figure Benitec Biopharma Limited RNA Based Therapeutics Business Revenue Market Share in 2016
Table Genzyme Corporation Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Genzyme Corporation (2012-2017)
Figure Genzyme Corporation RNA Based Therapeutics Business Revenue Market Share in 2016
Table ISIS pharmaceuticals Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of ISIS pharmaceuticals (2012-2017)
Figure ISIS pharmaceuticals RNA Based Therapeutics Business Revenue Market Share in 2016
Table Silence Therapeutics Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Silence Therapeutics (2012-2017)
Figure Silence Therapeutics RNA Based Therapeutics Business Revenue Market Share in 2016
Table Cenix BioScience Basic Information List
Table RNA Based Therapeutics Business Revenue (Million USD) of Cenix BioScience (2012-2017)
Figure Cenix BioScience RNA Based Therapeutics Business Revenue Market Share in 2016
Table Global RNA Based Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global RNA Based Therapeutics Market Size Share by Type in 2012
Figure Global RNA Based Therapeutics Market Size Share by Type in 2013
Figure Global RNA Based Therapeutics Market Size Share by Type in 2014
Figure Global RNA Based Therapeutics Market Size Share by Type in 2015
Figure Global RNA Based Therapeutics Market Size Share by Type in 2016
Figure Global RNA Based Therapeutics Market Size Share by Type in 2017
Table Global RNA Based Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2012
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2013
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2014
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2015
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2016
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of RNA Based Therapeutics
Figure United States RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States RNA Based Therapeutics Market Size Share by Players in 2016
Figure United States RNA Based Therapeutics Market Size Share by Players in 2017
Figure EU RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU RNA Based Therapeutics Market Size Share by Players in 2016
Figure EU RNA Based Therapeutics Market Size Share by Players in 2017
Figure Japan RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan RNA Based Therapeutics Market Size Share by Players in 2016
Figure Japan RNA Based Therapeutics Market Size Share by Players in 2017
Figure China RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China RNA Based Therapeutics Market Size Share by Players in 2016
Figure China RNA Based Therapeutics Market Size Share by Players in 2017
Figure India RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India RNA Based Therapeutics Market Size Share by Players in 2016
Figure India RNA Based Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia RNA Based Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia RNA Based Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia RNA Based Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia RNA Based Therapeutics Market Size Share by Players in 2017
Figure Global RNA Based Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global RNA Based Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global RNA Based Therapeutics Market Size Share by Regions in 2017
Figure Global RNA Based Therapeutics Market Size Share by Regions in 2022
Figure United States RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia RNA Based Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global RNA Based Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global RNA Based Therapeutics Market Size Share by Type in 2017
Figure Global RNA Based Therapeutics Market Size Share by Type in 2022
Table Global RNA Based Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2017
Figure Global RNA Based Therapeutics Market Size (Million USD) by Application in 2022